HCA
October 25, 2024 - AI Summary
Overvalued by 51.2% based on the discounted cash flow analysis.
Market cap | $80.99 Billion |
---|---|
Enterprise Value | $122.99 Billion |
Dividend Yield | $2.64 (0.806880375293198%) |
Earnings per Share | $19.24 |
Beta | 1.69 |
Outstanding Shares | 256,762,999 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 13.85 |
---|---|
PEG | -3.63 |
Price to Sales | 1.18 |
Price to Book Ratio | 2.16 |
Enterprise Value to Revenue | 1.77 |
Enterprise Value to EBIT | 20.59 |
Enterprise Value to Net Income | 75 |
Total Debt to Enterprise | 0.36 |
Debt to Equity | 1.18 |
No data
No data
Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising more than 2,000 sites of care, including 187 hospitals, surgery centers, freestanding ERs, urgent care centers, and physician clini...